Pregled bibliografske jedinice broj: 604572
Osteopontin expression is an independent factor for survival in oral squamous cell carcinoma
Osteopontin expression is an independent factor for survival in oral squamous cell carcinoma // Abstracts of the 24th European Congress of Pathology ; u: Virchows Archiv 461 (2012) (S1)
Prag, Češka Republika, 2012. str. 138-138 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 604572 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Osteopontin expression is an independent factor for survival in oral squamous cell carcinoma
(Osteopontin expression is an independent factor for survival in oral squamous cell carcinoma.)
Autori
Avirović, Manuela ; Matušan-Ilijaš, Koviljka ; Cerović, Robert ; Juretić, Mirna ; Jonjić, Nives ; Lučin, Ksenija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the 24th European Congress of Pathology ; u: Virchows Archiv 461 (2012) (S1)
/ - , 2012, 138-138
Skup
European Congress of Pathology (24 ; 2012)
Mjesto i datum
Prag, Češka Republika, 08.09.2012. - 12.09.2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
carcinoma; oral; osteopontin; prognosis; tissue array analysis
Sažetak
Ostepontin (OPN) is phosphorilated glycoprotein involved in various physiological and pathological events, including tumor progression. The aim of this study was to analyze the expression of OPN in oral squamous cell carcinoma (OSCC), and to assess its prognostic significance. The expression of OPN was immunohistochemicaly analyzed in 86 OSCC tissue microarrays and compared with clinicopathological variables such as tumor size, nodal stage, WHO clinical stage, Ki-67 proliferation index, and patients' outcome. The expression of OPN protein was observed in OSCC tumor cells (tOPN) and various stromal cells (sOPN), including granulocytes, macrophages, lymphocytes, plasma cells, and fibroblasts. OPN expression was higher in OSCC tumor cells compared to adjacent normal mucosa (p< 0.001), and was associated with advanced nodal stage (p=0.03), WHO clinical stage (p=0.045), and poor clinical outcome (p=0.023). In multivariate analysis tOPN emerged as an independent factor for survival (p=0.049). There was no association between sOPN and clinicopathological variables, although a trend for higher sOPN toward the longer patients' survival was found (p=0.12). OPN protein is upregulated in OSCC. While tOPN is involved in OSCC progression and can independently predict the clinical outcome, the role of sOPN is probably different and needs to be further elucidated.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
062-0620095-0078 - Uloga osteopontina u progresiji tumora (Lučin, Ksenija, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Mirna Juretić
(autor)
Manuela Avirović
(autor)
Koviljka Matušan Ilijaš
(autor)
Robert Cerović
(autor)
Ksenija Jurinović
(autor)
Nives Jonjić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE